ZEISS India Strengthens Portfolio with the Launch of ZEISS ClearMind Lenses

▴ ZEISS India
Introducing are first-of-its-kind ZEISS prescription lenses to provide extremely clear vision designed to reduce cognitive load.

National, 1st April: ZEISS, a pioneer of science in optics announces the launch its latest prescription lenses ZEISS ClearMind lenses in India. The all-day lenses addition to the lens portfolio delivers clear vision while reducing cognitive load due to blur for daily eyeglass wearers. For eye care professionals this offering elevates their practice with advanced lens technology that supports both visual performance and comfort.

 

In today’s fast-paced world with countless visual stimuli to process, there is an increase in information overload where individuals may feel overwhelmed. With pre-existing conditions of blur on spectacle lenses, the ability to identify and interpret complex stimuli is compromised. ZEISS ClearMind lenses are built on a unique design that reduces and smooths optical errors, increasing the clear vision zones and reducing peripheral lens blur thus reducing cognitive load.

 

Commenting on the addition to the lens portfolio, Rohan Paul, Business Head – India & Neighboring Markets, Vision Care, ZEISS India, said, “At ZEISS, innovation is at the core of everything we do. We are committed to protecting vision & visual health of world’s consumers. The launch of ZEISS ClearMind lenses reflects our continued focus on developing advanced optical solutions that enable individuals to see better, clearer and experience better comfort in their daily lives. We look forward to the positive impact these lenses will have, in collaboration with our valued business partners, as we continue to reach individuals seeking effective and personalized eye care solutions.”

 

Benefits of ZEISS ClearMind lenses at a glance

  • ZEISS ClearMind is a new, premium, all-day lens portfolio with larger zones of clear vision  embedded with ZEISS NeurOptix technology
  • In consumer studies, 96 % of wearers confirmed extremely clear vision. 9 out of 10 wearers also experienced less cognitive load in a blind test compared to a standard ZEISS progressive lens
  • The lenses are available for all age groups to promote perceived overall well-being, and good vision

 

Backed by scientific research to reduce cognitive load

Research conducted at the ZEISS Vision Science Lab (Tübingen University, Germany) established a direct connection between lens-induced blur and increased cognitive load. In consumer studies, 96% of wearers reported extremely clear vision when using ZEISS ClearMind lenses. 9 out of 10 wearers experienced reduced cognitive load compared to standard progressive lenses. Many wearers also reported an improvement in overall well-being while using the lenses. They also highlighted the importance of comfortable vision while staying focused for long hours.

 

 

Embedded with ZEISS NeurOptix technology for improved visual clarity

By aligning lens clarity zones to natural eye-movement patterns, ZEISS NeurOptix technology aims to reduce the brain’s cognitive load, provide more relaxed, effortless vision, as well as improve comfort during long days of digital, visually busy and dynamic activity. As a result, ZEISS Progressive ClearMind lenses offer up to 41% larger near-vision zones compared to ZEISS SmartLife progressive lenses. The technology also supports fast adaptation. 88% of wearers adjust within a few days, and over half within just an hour.

 

All-day lens portfolio includes single vision, progressive and digital focal types

ZEISS Single Vision ClearMind lenses are designed for 18+ wearers with blurry vision near or far. They reduce peripheral blur and provide larger clear vision zones than standard ZEISS lenses. ZEISS Digital ClearMind lenses are made for 35+ wearers experiencing blurry vision and tired eyes. They reduce blur and offer larger vision zones than ZEISS Digital SmartLife lenses. The design supports natural viewing habits and ensures smooth transition to near vision. It also enables an easier shift to progressive lenses in the future. ZEISS Progressive ClearMind lenses are designed for 45+ wearers with presbyopia. They reduce and optimize peripheral blur, creating wider clear vision zones than ZEISS SmartLife progressive lenses. They support smooth transitions across distances and improve overall visual flow.

 

For more details on ZEISS ClearMind lenses, Please visit ZEISS ClearMind At a Glance

About ZEISS Group:

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 12 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets.

 

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

 

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 15 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

 

With around 46,600 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026
Common Medical Terms Explained: A Plain-Language Guide for Indian Patients and Healthcare SeekersAugust 03, 2026
Why Radiology Is the Backbone of Modern Medical Diagnosis and TreatmentAugust 03, 2026
Managing Urban Stress: Science-Backed Strategies for Mental Resilience in 2026 August 01, 2026
Managing Chronic Inflammation: The Role of Anti-Inflammatory Indian SuperfoodsAugust 01, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 01, 2026
Early Markers of Glaucoma: Structural vs. Functional Ophthalmic Diagnostic ProtocolsAugust 01, 2026
Managing Complex Diabetic Foot Ulcers: Multidisciplinary Wound Care, Offloading, and RevascularizationAugust 01, 2026
The Future of Preventive Medicine: How India Is Moving From Cure to PreventionAugust 01, 2026
Why Young Indians Are Facing Heart Problems: Causes, Symptoms, and PreventionAugust 01, 2026
The Future of Preventive Screening: AI-Driven Early Cancer Detection in IndiaJuly 31, 2026
The Impact of Climate Change on Allergic Respiratory Diseases in Indian Cities July 31, 2026
Electronic Medical Records: What They Are, Why They Matter, and How India Is Embracing ThemJuly 31, 2026
Heatwave Health Risks in India: Symptoms, Treatment, and Prevention StrategiesJuly 31, 2026
Rare Chest Wall Reconstruction at SRM Global Hospital Saves Critically Injured Road Accident VictimJuly 30, 2026
52-Year-Old Male with just 10% Heart Function successfully revived at Fortis Greater Noida via High-Risk Emergency AngioplastyJuly 30, 2026
Yashoda Hospitals Hitec City Achieves Landmark Milestone of 400+ Renal Transplants in less than 4 YearsJuly 30, 2026